Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01425762 · ClinicalTrials.gov registry record · NA
Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01425762: Completed NA study, sponsored by Stanford University.
NCT01425762 is a NA study that has completed, run by Stanford University. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01425762, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
This is a randomized controlled study that will place patients into a "choice" and a "no choice" group. The choice group will be able to choose between receiving 100 mcg or 200 mcg intrathecal morphine. The no choice group will be randomized to receive either 100 mcg or 200 mcg of intrathecal morphine. Following casarean delivery, pain scores will be measured at 3, 6, 12, 24, and 36 hours.
Interventions
- OTHER Drug Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01425762
The ClinicalTrials.gov registry entry for NCT01425762 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Drug Dose is the first listed.
NCT01425762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01425762 about?
NCT01425762 is a clinical study titled "Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.". This is a randomized controlled study that will place patients into a "choice" and a "no choice" group. The choice group will be able to choose between receiving 100 mcg or 200 mcg intrathecal morphine. The no choice group will be randomized to receive either 100 mcg or 200 mcg of intrathecal morphi...
What is the current status of trial NCT01425762?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2011-08. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01425762?
The interventions under investigation include: Drug Dose (OTHER).
Who is sponsoring clinical trial NCT01425762?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.